GO:0003723 | RNA binding | 38.52% (47/122) | 2.57 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 35.25% (43/122) | 2.56 | 0.0 | 0.0 |
GO:1990904 | ribonucleoprotein complex | 26.23% (32/122) | 3.2 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 42.62% (52/122) | 2.08 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 37.7% (46/122) | 2.19 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 38.52% (47/122) | 2.13 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 38.52% (47/122) | 2.13 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 47.54% (58/122) | 1.71 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 61.48% (75/122) | 1.31 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 43.44% (53/122) | 1.81 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 61.48% (75/122) | 1.3 | 0.0 | 0.0 |
GO:0005730 | nucleolus | 24.59% (30/122) | 2.82 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 45.08% (55/122) | 1.73 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 44.26% (54/122) | 1.75 | 0.0 | 0.0 |
GO:0005515 | protein binding | 74.59% (91/122) | 0.98 | 0.0 | 0.0 |
GO:0003729 | mRNA binding | 25.41% (31/122) | 2.57 | 0.0 | 0.0 |
GO:0050684 | regulation of mRNA processing | 12.3% (15/122) | 4.36 | 0.0 | 0.0 |
GO:0005488 | binding | 84.43% (103/122) | 0.75 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 45.08% (55/122) | 1.58 | 0.0 | 0.0 |
GO:0060255 | regulation of macromolecule metabolic process | 45.9% (56/122) | 1.54 | 0.0 | 0.0 |
GO:0006396 | RNA processing | 24.59% (30/122) | 2.51 | 0.0 | 0.0 |
GO:0010628 | positive regulation of gene expression | 18.85% (23/122) | 3.0 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 45.08% (55/122) | 1.45 | 0.0 | 0.0 |
GO:0010468 | regulation of gene expression | 39.34% (48/122) | 1.62 | 0.0 | 0.0 |
GO:0051171 | regulation of nitrogen compound metabolic process | 41.8% (51/122) | 1.52 | 0.0 | 0.0 |
GO:0009987 | cellular process | 83.61% (102/122) | 0.68 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 52.46% (64/122) | 1.23 | 0.0 | 0.0 |
GO:0051246 | regulation of protein metabolic process | 25.41% (31/122) | 2.2 | 0.0 | 0.0 |
GO:0080090 | regulation of primary metabolic process | 42.62% (52/122) | 1.46 | 0.0 | 0.0 |
GO:0010605 | negative regulation of macromolecule metabolic process | 28.69% (35/122) | 1.98 | 0.0 | 0.0 |
GO:0008150 | biological_process | 90.16% (110/122) | 0.55 | 0.0 | 0.0 |
GO:0050789 | regulation of biological process | 64.75% (79/122) | 0.95 | 0.0 | 0.0 |
GO:0065007 | biological regulation | 68.03% (83/122) | 0.89 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 58.2% (71/122) | 1.06 | 0.0 | 0.0 |
GO:1903311 | regulation of mRNA metabolic process | 12.3% (15/122) | 3.55 | 0.0 | 0.0 |
GO:0031324 | negative regulation of cellular metabolic process | 25.41% (31/122) | 2.09 | 0.0 | 0.0 |
GO:0009892 | negative regulation of metabolic process | 29.51% (36/122) | 1.87 | 0.0 | 0.0 |
GO:0140513 | nuclear protein-containing complex | 20.49% (25/122) | 2.43 | 0.0 | 0.0 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 25.41% (31/122) | 2.07 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 87.7% (107/122) | 0.55 | 0.0 | 0.0 |
GO:0019222 | regulation of metabolic process | 45.9% (56/122) | 1.25 | 0.0 | 0.0 |
GO:0005681 | spliceosomal complex | 10.66% (13/122) | 3.73 | 0.0 | 0.0 |
GO:0050794 | regulation of cellular process | 58.2% (71/122) | 1.0 | 0.0 | 0.0 |
GO:0071425 | hematopoietic stem cell proliferation | 4.1% (5/122) | 7.48 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 63.11% (77/122) | 0.9 | 0.0 | 0.0 |
GO:0030684 | preribosome | 8.2% (10/122) | 4.43 | 0.0 | 0.0 |
GO:0022618 | ribonucleoprotein complex assembly | 10.66% (13/122) | 3.64 | 0.0 | 0.0 |
GO:0031323 | regulation of cellular metabolic process | 40.98% (50/122) | 1.33 | 0.0 | 0.0 |
GO:0071826 | ribonucleoprotein complex subunit organization | 10.66% (13/122) | 3.55 | 0.0 | 0.0 |
GO:0005829 | cytosol | 37.7% (46/122) | 1.4 | 0.0 | 0.0 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 31.97% (39/122) | 1.57 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 86.89% (106/122) | 0.51 | 0.0 | 0.0 |
GO:0006913 | nucleocytoplasmic transport | 9.02% (11/122) | 3.87 | 0.0 | 0.0 |
GO:0034470 | ncRNA processing | 14.75% (18/122) | 2.71 | 0.0 | 0.0 |
GO:0051169 | nuclear transport | 9.02% (11/122) | 3.86 | 0.0 | 0.0 |
GO:0043484 | regulation of RNA splicing | 9.02% (11/122) | 3.84 | 0.0 | 0.0 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 8.2% (10/122) | 4.11 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 59.02% (72/122) | 0.89 | 0.0 | 0.0 |
GO:0006364 | rRNA processing | 10.66% (13/122) | 3.33 | 0.0 | 0.0 |
GO:0034660 | ncRNA metabolic process | 15.57% (19/122) | 2.52 | 0.0 | 0.0 |
GO:0010608 | post-transcriptional regulation of gene expression | 13.93% (17/122) | 2.72 | 0.0 | 0.0 |
GO:0010604 | positive regulation of macromolecule metabolic process | 27.05% (33/122) | 1.69 | 0.0 | 0.0 |
GO:0098508 | endothelial to hematopoietic transition | 3.28% (4/122) | 7.74 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 85.25% (104/122) | 0.5 | 0.0 | 0.0 |
GO:0048519 | negative regulation of biological process | 37.7% (46/122) | 1.3 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 63.93% (78/122) | 0.79 | 0.0 | 0.0 |
GO:0008380 | RNA splicing | 9.84% (12/122) | 3.39 | 0.0 | 0.0 |
GO:0048522 | positive regulation of cellular process | 35.25% (43/122) | 1.35 | 0.0 | 0.0 |
GO:0022607 | cellular component assembly | 22.95% (28/122) | 1.86 | 0.0 | 0.0 |
GO:0016072 | rRNA metabolic process | 10.66% (13/122) | 3.18 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 66.39% (81/122) | 0.74 | 0.0 | 0.0 |
GO:0048523 | negative regulation of cellular process | 31.15% (38/122) | 1.48 | 0.0 | 0.0 |
GO:0036002 | pre-mRNA binding | 5.74% (7/122) | 4.98 | 0.0 | 0.0 |
GO:0040012 | regulation of locomotion | 9.84% (12/122) | 3.33 | 0.0 | 0.0 |
GO:0060232 | delamination | 3.28% (4/122) | 7.52 | 0.0 | 0.0 |
GO:0043021 | ribonucleoprotein complex binding | 8.2% (10/122) | 3.79 | 0.0 | 0.0 |
GO:0016604 | nuclear body | 12.3% (15/122) | 2.83 | 0.0 | 0.0 |
GO:0006446 | regulation of translational initiation | 5.74% (7/122) | 4.85 | 0.0 | 0.0 |
GO:0048518 | positive regulation of biological process | 39.34% (48/122) | 1.19 | 0.0 | 0.0 |
GO:0010629 | negative regulation of gene expression | 13.93% (17/122) | 2.53 | 0.0 | 0.0 |
GO:0005654 | nucleoplasm | 18.85% (23/122) | 2.05 | 0.0 | 0.0 |
GO:0010556 | regulation of macromolecule biosynthetic process | 29.51% (36/122) | 1.47 | 0.0 | 0.0 |
GO:0040013 | negative regulation of locomotion | 5.74% (7/122) | 4.72 | 0.0 | 0.0 |
GO:0006417 | regulation of translation | 11.48% (14/122) | 2.84 | 0.0 | 0.0 |
GO:0016071 | mRNA metabolic process | 13.93% (17/122) | 2.48 | 0.0 | 0.0 |
GO:0043226 | organelle | 65.57% (80/122) | 0.71 | 0.0 | 0.0 |
GO:0051248 | negative regulation of protein metabolic process | 13.11% (16/122) | 2.57 | 0.0 | 0.0 |
GO:0043933 | protein-containing complex organization | 17.21% (21/122) | 2.1 | 0.0 | 1e-06 |
GO:0022408 | negative regulation of cell-cell adhesion | 4.1% (5/122) | 5.84 | 0.0 | 1e-06 |
GO:0043229 | intracellular organelle | 64.75% (79/122) | 0.7 | 0.0 | 1e-06 |
GO:0030687 | preribosome, large subunit precursor | 4.92% (6/122) | 5.08 | 0.0 | 1e-06 |
GO:0034248 | regulation of cellular amide metabolic process | 11.48% (14/122) | 2.74 | 0.0 | 1e-06 |
GO:1902036 | regulation of hematopoietic stem cell differentiation | 3.28% (4/122) | 6.86 | 0.0 | 1e-06 |
GO:1903104 | obsolete regulation of insulin receptor signaling pathway involved in determination of adult lifespan | 2.46% (3/122) | 8.32 | 0.0 | 1e-06 |
GO:0009893 | positive regulation of metabolic process | 27.05% (33/122) | 1.49 | 0.0 | 1e-06 |
GO:0051247 | positive regulation of protein metabolic process | 13.93% (17/122) | 2.36 | 0.0 | 1e-06 |
GO:0035639 | purine ribonucleoside triphosphate binding | 20.49% (25/122) | 1.8 | 0.0 | 1e-06 |
GO:0043022 | ribosome binding | 5.74% (7/122) | 4.43 | 0.0 | 1e-06 |
GO:0000469 | cleavage involved in rRNA processing | 5.74% (7/122) | 4.42 | 0.0 | 1e-06 |
GO:0045948 | positive regulation of translational initiation | 4.1% (5/122) | 5.69 | 0.0 | 1e-06 |
GO:0045727 | positive regulation of translation | 7.38% (9/122) | 3.67 | 0.0 | 1e-06 |
GO:0065003 | protein-containing complex assembly | 15.57% (19/122) | 2.16 | 0.0 | 1e-06 |
GO:0000470 | maturation of LSU-rRNA | 4.92% (6/122) | 4.91 | 0.0 | 1e-06 |
GO:0097367 | carbohydrate derivative binding | 22.13% (27/122) | 1.68 | 0.0 | 1e-06 |
GO:0051252 | regulation of RNA metabolic process | 27.05% (33/122) | 1.45 | 0.0 | 2e-06 |
GO:0000054 | ribosomal subunit export from nucleus | 4.1% (5/122) | 5.56 | 0.0 | 2e-06 |
GO:0033750 | ribosome localization | 4.1% (5/122) | 5.56 | 0.0 | 2e-06 |
GO:0000375 | RNA splicing, via transesterification reactions | 7.38% (9/122) | 3.56 | 0.0 | 2e-06 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 16.39% (20/122) | 2.03 | 0.0 | 2e-06 |
GO:0030336 | negative regulation of cell migration | 4.92% (6/122) | 4.76 | 0.0 | 2e-06 |
GO:0016043 | cellular component organization | 36.07% (44/122) | 1.14 | 0.0 | 2e-06 |
GO:0072089 | stem cell proliferation | 4.1% (5/122) | 5.44 | 0.0 | 3e-06 |
GO:0033341 | regulation of collagen binding | 2.46% (3/122) | 7.91 | 0.0 | 3e-06 |
GO:0033342 | negative regulation of collagen binding | 2.46% (3/122) | 7.91 | 0.0 | 3e-06 |
GO:2000146 | negative regulation of cell motility | 4.92% (6/122) | 4.72 | 0.0 | 3e-06 |
GO:0034250 | positive regulation of cellular amide metabolic process | 7.38% (9/122) | 3.48 | 0.0 | 3e-06 |
GO:0032555 | purine ribonucleotide binding | 20.49% (25/122) | 1.69 | 0.0 | 4e-06 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 22.95% (28/122) | 1.56 | 0.0 | 4e-06 |
GO:0000398 | mRNA splicing, via spliceosome | 6.56% (8/122) | 3.73 | 0.0 | 4e-06 |
GO:0017076 | purine nucleotide binding | 20.49% (25/122) | 1.68 | 0.0 | 4e-06 |
GO:0071840 | cellular component organization or biogenesis | 36.89% (45/122) | 1.08 | 0.0 | 5e-06 |
GO:0051082 | unfolded protein binding | 6.56% (8/122) | 3.69 | 0.0 | 5e-06 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.1% (5/122) | 5.22 | 0.0 | 5e-06 |
GO:0007162 | negative regulation of cell adhesion | 4.1% (5/122) | 5.19 | 0.0 | 6e-06 |
GO:0022407 | regulation of cell-cell adhesion | 4.92% (6/122) | 4.52 | 0.0 | 6e-06 |
GO:0032553 | ribonucleotide binding | 20.49% (25/122) | 1.65 | 0.0 | 6e-06 |
GO:0032774 | RNA biosynthetic process | 8.2% (10/122) | 3.11 | 0.0 | 6e-06 |
GO:0009889 | regulation of biosynthetic process | 30.33% (37/122) | 1.25 | 0.0 | 6e-06 |
GO:0009059 | macromolecule biosynthetic process | 15.57% (19/122) | 1.99 | 0.0 | 6e-06 |
GO:0060339 | negative regulation of type I interferon-mediated signaling pathway | 3.28% (4/122) | 6.08 | 0.0 | 7e-06 |
GO:0051726 | regulation of cell cycle | 13.11% (16/122) | 2.22 | 0.0 | 7e-06 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 11.48% (14/122) | 2.42 | 0.0 | 8e-06 |
GO:0031326 | regulation of cellular biosynthetic process | 29.51% (36/122) | 1.25 | 0.0 | 8e-06 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 15.57% (19/122) | 1.96 | 0.0 | 8e-06 |
GO:0031647 | regulation of protein stability | 8.2% (10/122) | 3.05 | 0.0 | 8e-06 |
GO:1903313 | positive regulation of mRNA metabolic process | 6.56% (8/122) | 3.58 | 0.0 | 8e-06 |
GO:0045746 | negative regulation of Notch signaling pathway | 3.28% (4/122) | 6.0 | 0.0 | 8e-06 |
GO:0030334 | regulation of cell migration | 7.38% (9/122) | 3.26 | 0.0 | 9e-06 |
GO:0051128 | regulation of cellular component organization | 18.85% (23/122) | 1.7 | 1e-06 | 1e-05 |
GO:2000145 | regulation of cell motility | 7.38% (9/122) | 3.24 | 1e-06 | 1.1e-05 |
GO:0005525 | GTP binding | 7.38% (9/122) | 3.22 | 1e-06 | 1.1e-05 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 3.28% (4/122) | 5.86 | 1e-06 | 1.2e-05 |
GO:0017148 | negative regulation of translation | 6.56% (8/122) | 3.49 | 1e-06 | 1.2e-05 |
GO:0034063 | stress granule assembly | 4.1% (5/122) | 4.86 | 1e-06 | 1.6e-05 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6.56% (8/122) | 3.44 | 1e-06 | 1.6e-05 |
GO:0044877 | protein-containing complex binding | 12.3% (15/122) | 2.21 | 1e-06 | 1.7e-05 |
GO:0034249 | negative regulation of cellular amide metabolic process | 6.56% (8/122) | 3.42 | 1e-06 | 1.7e-05 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 6.56% (8/122) | 3.42 | 1e-06 | 1.7e-05 |
GO:0043168 | anion binding | 22.95% (28/122) | 1.44 | 1e-06 | 1.7e-05 |
GO:0006397 | mRNA processing | 9.02% (11/122) | 2.73 | 1e-06 | 1.7e-05 |
GO:0050821 | protein stabilization | 6.56% (8/122) | 3.41 | 1e-06 | 1.7e-05 |
GO:0007284 | spermatogonial cell division | 2.46% (3/122) | 7.1 | 1e-06 | 1.8e-05 |
GO:1902626 | assembly of large subunit precursor of preribosome | 2.46% (3/122) | 7.1 | 1e-06 | 1.8e-05 |
GO:0018885 | carbon tetrachloride metabolic process | 2.46% (3/122) | 7.1 | 1e-06 | 1.8e-05 |
GO:0031327 | negative regulation of cellular biosynthetic process | 15.57% (19/122) | 1.87 | 1e-06 | 1.9e-05 |
GO:0050771 | negative regulation of axonogenesis | 3.28% (4/122) | 5.68 | 1e-06 | 1.9e-05 |
GO:0032561 | guanyl ribonucleotide binding | 7.38% (9/122) | 3.09 | 1e-06 | 2.2e-05 |
GO:0019001 | guanyl nucleotide binding | 7.38% (9/122) | 3.08 | 1e-06 | 2.3e-05 |
GO:0042127 | regulation of cell population proliferation | 11.48% (14/122) | 2.26 | 1e-06 | 2.5e-05 |
GO:0009890 | negative regulation of biosynthetic process | 15.57% (19/122) | 1.83 | 2e-06 | 2.6e-05 |
GO:0016607 | nuclear speck | 7.38% (9/122) | 3.05 | 2e-06 | 2.7e-05 |
GO:0062153 | C5-methylcytidine-containing RNA binding | 2.46% (3/122) | 6.91 | 2e-06 | 2.7e-05 |
GO:1901163 | regulation of trophoblast cell migration | 2.46% (3/122) | 6.91 | 2e-06 | 2.7e-05 |
GO:0030317 | flagellated sperm motility | 3.28% (4/122) | 5.52 | 2e-06 | 2.8e-05 |
GO:0060285 | cilium-dependent cell motility | 3.28% (4/122) | 5.52 | 2e-06 | 2.8e-05 |
GO:0060294 | cilium movement involved in cell motility | 3.28% (4/122) | 5.52 | 2e-06 | 2.8e-05 |
GO:0097722 | sperm motility | 3.28% (4/122) | 5.52 | 2e-06 | 2.8e-05 |
GO:0042026 | protein refolding | 4.1% (5/122) | 4.62 | 2e-06 | 3.1e-05 |
GO:0051129 | negative regulation of cellular component organization | 8.2% (10/122) | 2.8 | 2e-06 | 3.1e-05 |
GO:0031325 | positive regulation of cellular metabolic process | 22.13% (27/122) | 1.42 | 2e-06 | 3.2e-05 |
GO:0001960 | negative regulation of cytokine-mediated signaling pathway | 3.28% (4/122) | 5.47 | 2e-06 | 3.2e-05 |
GO:0060761 | negative regulation of response to cytokine stimulus | 3.28% (4/122) | 5.42 | 2e-06 | 3.6e-05 |
GO:0001539 | cilium or flagellum-dependent cell motility | 3.28% (4/122) | 5.42 | 2e-06 | 3.6e-05 |
GO:0002577 | regulation of antigen processing and presentation | 2.46% (3/122) | 6.74 | 2e-06 | 3.8e-05 |
GO:1905258 | regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway | 2.46% (3/122) | 6.74 | 2e-06 | 3.8e-05 |
GO:1905259 | negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway | 2.46% (3/122) | 6.74 | 2e-06 | 3.8e-05 |
GO:2000736 | regulation of stem cell differentiation | 4.1% (5/122) | 4.52 | 3e-06 | 4.3e-05 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 4.92% (6/122) | 3.92 | 3e-06 | 4.7e-05 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 6.56% (8/122) | 3.18 | 3e-06 | 4.7e-05 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 17.21% (21/122) | 1.64 | 3e-06 | 5e-05 |
GO:1900015 | regulation of cytokine production involved in inflammatory response | 2.46% (3/122) | 6.59 | 4e-06 | 5.2e-05 |
GO:0042197 | halogenated hydrocarbon metabolic process | 2.46% (3/122) | 6.59 | 4e-06 | 5.2e-05 |
GO:0034504 | protein localization to nucleus | 5.74% (7/122) | 3.48 | 3e-06 | 5.2e-05 |
GO:0000166 | nucleotide binding | 24.59% (30/122) | 1.28 | 4e-06 | 5.2e-05 |
GO:1901265 | nucleoside phosphate binding | 24.59% (30/122) | 1.28 | 4e-06 | 5.2e-05 |
GO:0043488 | regulation of mRNA stability | 5.74% (7/122) | 3.46 | 4e-06 | 5.6e-05 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 7.38% (9/122) | 2.86 | 5e-06 | 6.6e-05 |
GO:0065009 | regulation of molecular function | 16.39% (20/122) | 1.66 | 5e-06 | 6.8e-05 |
GO:0055131 | C3HC4-type RING finger domain binding | 2.46% (3/122) | 6.45 | 5e-06 | 6.9e-05 |
GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 4.1% (5/122) | 4.32 | 5e-06 | 7.7e-05 |
GO:0008156 | negative regulation of DNA replication | 3.28% (4/122) | 5.11 | 6e-06 | 7.8e-05 |
GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.1% (5/122) | 4.31 | 6e-06 | 8.1e-05 |
GO:0044260 | cellular macromolecule metabolic process | 22.13% (27/122) | 1.34 | 6e-06 | 8.1e-05 |
GO:0051098 | regulation of binding | 6.56% (8/122) | 3.06 | 6e-06 | 8.3e-05 |
GO:0045595 | regulation of cell differentiation | 10.66% (13/122) | 2.19 | 6e-06 | 8.5e-05 |
GO:0001959 | regulation of cytokine-mediated signaling pathway | 3.28% (4/122) | 5.04 | 7e-06 | 9.3e-05 |
GO:0000974 | Prp19 complex | 3.28% (4/122) | 5.04 | 7e-06 | 9.3e-05 |
GO:0043487 | regulation of RNA stability | 5.74% (7/122) | 3.31 | 8e-06 | 0.000102 |
GO:0006275 | regulation of DNA replication | 4.92% (6/122) | 3.69 | 8e-06 | 0.000104 |
GO:0051168 | nuclear export | 4.92% (6/122) | 3.69 | 8e-06 | 0.000104 |
GO:0006606 | protein import into nucleus | 4.1% (5/122) | 4.22 | 8e-06 | 0.000105 |
GO:0000478 | endonucleolytic cleavage involved in rRNA processing | 4.1% (5/122) | 4.22 | 8e-06 | 0.000105 |
GO:1990247 | N6-methyladenosine-containing RNA binding | 2.46% (3/122) | 6.21 | 8e-06 | 0.000108 |
GO:0035061 | interchromatin granule | 2.46% (3/122) | 6.21 | 8e-06 | 0.000108 |
GO:0050779 | RNA destabilization | 4.1% (5/122) | 4.2 | 8e-06 | 0.000109 |
GO:0061157 | mRNA destabilization | 4.1% (5/122) | 4.2 | 8e-06 | 0.000109 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 9.84% (12/122) | 2.26 | 8e-06 | 0.000109 |
GO:0003341 | cilium movement | 3.28% (4/122) | 4.93 | 9e-06 | 0.000118 |
GO:0006352 | DNA-templated transcription initiation | 4.1% (5/122) | 4.17 | 9e-06 | 0.000119 |
GO:0036094 | small molecule binding | 25.41% (31/122) | 1.18 | 9e-06 | 0.000119 |
GO:0061013 | regulation of mRNA catabolic process | 5.74% (7/122) | 3.26 | 9e-06 | 0.00012 |
GO:0008806 | carboxymethylenebutenolidase activity | 1.64% (2/122) | 8.32 | 1e-05 | 0.000123 |
GO:0051253 | negative regulation of RNA metabolic process | 13.11% (16/122) | 1.84 | 1e-05 | 0.000131 |
GO:1901532 | regulation of hematopoietic progenitor cell differentiation | 3.28% (4/122) | 4.86 | 1.1e-05 | 0.00014 |
GO:0051239 | regulation of multicellular organismal process | 20.49% (25/122) | 1.35 | 1.2e-05 | 0.000146 |
GO:0006457 | protein folding | 6.56% (8/122) | 2.92 | 1.2e-05 | 0.00015 |
GO:0060759 | regulation of response to cytokine stimulus | 3.28% (4/122) | 4.83 | 1.2e-05 | 0.000152 |
GO:0019843 | rRNA binding | 5.74% (7/122) | 3.2 | 1.2e-05 | 0.000153 |
GO:0010494 | cytoplasmic stress granule | 4.92% (6/122) | 3.56 | 1.3e-05 | 0.00016 |
GO:0010888 | negative regulation of lipid storage | 2.46% (3/122) | 6.0 | 1.3e-05 | 0.00016 |
GO:0007219 | Notch signaling pathway | 2.46% (3/122) | 6.0 | 1.3e-05 | 0.00016 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 6.56% (8/122) | 2.87 | 1.5e-05 | 0.000184 |
GO:1901998 | toxin transport | 3.28% (4/122) | 4.74 | 1.6e-05 | 0.000191 |
GO:0030517 | negative regulation of axon extension | 2.46% (3/122) | 5.91 | 1.6e-05 | 0.000193 |
GO:0006607 | NLS-bearing protein import into nucleus | 2.46% (3/122) | 5.91 | 1.6e-05 | 0.000193 |
GO:0030155 | regulation of cell adhesion | 4.92% (6/122) | 3.47 | 1.9e-05 | 0.000225 |
GO:0031328 | positive regulation of cellular biosynthetic process | 17.21% (21/122) | 1.46 | 2.2e-05 | 0.000259 |
GO:0048583 | regulation of response to stimulus | 27.87% (34/122) | 1.04 | 2.4e-05 | 0.000273 |
GO:0009408 | response to heat | 10.66% (13/122) | 2.0 | 2.3e-05 | 0.000273 |
GO:1902667 | regulation of axon guidance | 2.46% (3/122) | 5.74 | 2.3e-05 | 0.000273 |
GO:1905953 | negative regulation of lipid localization | 2.46% (3/122) | 5.74 | 2.3e-05 | 0.000273 |
GO:0010596 | negative regulation of endothelial cell migration | 2.46% (3/122) | 5.74 | 2.3e-05 | 0.000273 |
GO:0010646 | regulation of cell communication | 19.67% (24/122) | 1.33 | 2.3e-05 | 0.000273 |
GO:0003924 | GTPase activity | 5.74% (7/122) | 3.04 | 2.5e-05 | 0.000293 |
GO:0051170 | import into nucleus | 4.1% (5/122) | 3.84 | 2.8e-05 | 0.000322 |
GO:0009891 | positive regulation of biosynthetic process | 17.21% (21/122) | 1.44 | 2.8e-05 | 0.000322 |
GO:0044087 | regulation of cellular component biogenesis | 9.02% (11/122) | 2.2 | 2.9e-05 | 0.000331 |
GO:0010977 | negative regulation of neuron projection development | 3.28% (4/122) | 4.52 | 2.9e-05 | 0.000332 |
GO:0050768 | negative regulation of neurogenesis | 3.28% (4/122) | 4.52 | 2.9e-05 | 0.000332 |
GO:0080134 | regulation of response to stress | 19.67% (24/122) | 1.31 | 2.9e-05 | 0.000332 |
GO:0016462 | pyrophosphatase activity | 7.38% (9/122) | 2.52 | 3.1e-05 | 0.000346 |
GO:0051961 | negative regulation of nervous system development | 3.28% (4/122) | 4.49 | 3.1e-05 | 0.00035 |
GO:1900271 | regulation of long-term synaptic potentiation | 2.46% (3/122) | 5.59 | 3.3e-05 | 0.000361 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 7.38% (9/122) | 2.5 | 3.4e-05 | 0.00038 |
GO:0008593 | regulation of Notch signaling pathway | 3.28% (4/122) | 4.44 | 3.6e-05 | 0.000395 |
GO:0101031 | chaperone complex | 3.28% (4/122) | 4.44 | 3.6e-05 | 0.000395 |
GO:0008283 | cell population proliferation | 4.92% (6/122) | 3.29 | 3.7e-05 | 0.000401 |
GO:2000241 | regulation of reproductive process | 13.93% (17/122) | 1.62 | 3.7e-05 | 0.000405 |
GO:0030521 | androgen receptor signaling pathway | 2.46% (3/122) | 5.52 | 3.8e-05 | 0.00041 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 6.56% (8/122) | 2.68 | 3.8e-05 | 0.000415 |
GO:0035770 | ribonucleoprotein granule | 6.56% (8/122) | 2.66 | 4.3e-05 | 0.000459 |
GO:0003730 | mRNA 3'-UTR binding | 4.1% (5/122) | 3.7 | 4.4e-05 | 0.000466 |
GO:0051100 | negative regulation of binding | 4.1% (5/122) | 3.7 | 4.4e-05 | 0.000466 |
GO:0042769 | obsolete DNA damage response, detection of DNA damage | 2.46% (3/122) | 5.45 | 4.4e-05 | 0.000468 |
GO:0051179 | localization | 27.05% (33/122) | 1.02 | 4.5e-05 | 0.000473 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 7.38% (9/122) | 2.44 | 4.6e-05 | 0.00048 |
GO:2001234 | negative regulation of apoptotic signaling pathway | 4.1% (5/122) | 3.68 | 4.7e-05 | 0.000498 |
GO:0005524 | ATP binding | 14.75% (18/122) | 1.53 | 5e-05 | 0.000518 |
GO:0010633 | negative regulation of epithelial cell migration | 2.46% (3/122) | 5.39 | 5e-05 | 0.000523 |
GO:0006810 | transport | 23.77% (29/122) | 1.1 | 5.5e-05 | 0.000566 |
GO:0030581 | symbiont intracellular protein transport in host | 1.64% (2/122) | 7.32 | 5.8e-05 | 0.000586 |
GO:0075506 | entry of viral genome into host nucleus through nuclear pore complex via importin | 1.64% (2/122) | 7.32 | 5.8e-05 | 0.000586 |
GO:0075732 | viral penetration into host nucleus | 1.64% (2/122) | 7.32 | 5.8e-05 | 0.000586 |
GO:0080034 | host response to induction by symbiont of tumor, nodule or growth in host | 1.64% (2/122) | 7.32 | 5.8e-05 | 0.000586 |
GO:1900017 | positive regulation of cytokine production involved in inflammatory response | 1.64% (2/122) | 7.32 | 5.8e-05 | 0.000586 |
GO:1903538 | regulation of meiotic cell cycle process involved in oocyte maturation | 2.46% (3/122) | 5.32 | 5.7e-05 | 0.000592 |
GO:0051087 | chaperone binding | 4.1% (5/122) | 3.59 | 6.4e-05 | 0.000644 |
GO:0031053 | primary miRNA processing | 2.46% (3/122) | 5.26 | 6.5e-05 | 0.000653 |
GO:0032502 | developmental process | 43.44% (53/122) | 0.69 | 6.7e-05 | 0.00067 |
GO:0061014 | positive regulation of mRNA catabolic process | 4.1% (5/122) | 3.56 | 7.1e-05 | 0.000705 |
GO:0010721 | negative regulation of cell development | 3.28% (4/122) | 4.19 | 7.1e-05 | 0.000706 |
GO:0090084 | negative regulation of inclusion body assembly | 2.46% (3/122) | 5.21 | 7.3e-05 | 0.000726 |
GO:0051851 | modulation by host of symbiont process | 3.28% (4/122) | 4.17 | 7.5e-05 | 0.000738 |
GO:0031503 | protein-containing complex localization | 4.1% (5/122) | 3.52 | 8.1e-05 | 0.0008 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 9.84% (12/122) | 1.92 | 8.3e-05 | 0.000812 |
GO:0009894 | regulation of catabolic process | 9.84% (12/122) | 1.92 | 8.4e-05 | 0.000824 |
GO:0030516 | regulation of axon extension | 3.28% (4/122) | 4.11 | 8.8e-05 | 0.000855 |
GO:1902494 | catalytic complex | 13.93% (17/122) | 1.52 | 8.9e-05 | 0.000864 |
GO:0071013 | catalytic step 2 spliceosome | 4.1% (5/122) | 3.48 | 9.3e-05 | 0.000897 |
GO:0099080 | supramolecular complex | 9.84% (12/122) | 1.9 | 9.3e-05 | 0.000899 |
GO:0071540 | eukaryotic translation initiation factor 3 complex, eIF3e | 1.64% (2/122) | 7.0 | 9.6e-05 | 0.000922 |
GO:0031345 | negative regulation of cell projection organization | 3.28% (4/122) | 4.08 | 9.7e-05 | 0.000929 |
GO:0031397 | negative regulation of protein ubiquitination | 3.28% (4/122) | 4.08 | 9.7e-05 | 0.000929 |
GO:0099523 | presynaptic cytosol | 2.46% (3/122) | 5.05 | 0.000102 | 0.000967 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.46% (3/122) | 5.05 | 0.000102 | 0.000967 |
GO:0042981 | regulation of apoptotic process | 8.2% (10/122) | 2.13 | 0.000107 | 0.00101 |
GO:0051028 | mRNA transport | 4.1% (5/122) | 3.43 | 0.000109 | 0.001024 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 13.93% (17/122) | 1.49 | 0.000115 | 0.001078 |
GO:0007018 | microtubule-based movement | 4.92% (6/122) | 2.98 | 0.00012 | 0.001118 |
GO:0051234 | establishment of localization | 23.77% (29/122) | 1.04 | 0.00012 | 0.001121 |
GO:0019220 | regulation of phosphate metabolic process | 8.2% (10/122) | 2.1 | 0.000122 | 0.001132 |
GO:0032559 | adenyl ribonucleotide binding | 14.75% (18/122) | 1.42 | 0.000128 | 0.001186 |
GO:0050770 | regulation of axonogenesis | 3.28% (4/122) | 3.97 | 0.000131 | 0.001201 |
GO:0048471 | perinuclear region of cytoplasm | 6.56% (8/122) | 2.43 | 0.000131 | 0.001204 |
GO:0030554 | adenyl nucleotide binding | 14.75% (18/122) | 1.41 | 0.000137 | 0.001251 |
GO:2000737 | negative regulation of stem cell differentiation | 2.46% (3/122) | 4.91 | 0.000138 | 0.001255 |
GO:0051240 | positive regulation of multicellular organismal process | 9.84% (12/122) | 1.84 | 0.000139 | 0.00126 |
GO:0051174 | regulation of phosphorus metabolic process | 8.2% (10/122) | 2.08 | 0.000139 | 0.001263 |
GO:0006414 | translational elongation | 3.28% (4/122) | 3.93 | 0.000144 | 0.001297 |
GO:0061387 | regulation of extent of cell growth | 3.28% (4/122) | 3.91 | 0.00015 | 0.001353 |
GO:0061077 | chaperone-mediated protein folding | 4.1% (5/122) | 3.32 | 0.000152 | 0.001364 |
GO:1903321 | negative regulation of protein modification by small protein conjugation or removal | 3.28% (4/122) | 3.88 | 0.000165 | 0.00147 |
GO:0000932 | P-body | 4.1% (5/122) | 3.3 | 0.000166 | 0.001472 |
GO:0006959 | humoral immune response | 2.46% (3/122) | 4.82 | 0.000165 | 0.001473 |
GO:0046034 | ATP metabolic process | 4.1% (5/122) | 3.29 | 0.000171 | 0.00151 |
GO:0009966 | regulation of signal transduction | 17.21% (21/122) | 1.25 | 0.000172 | 0.001518 |
GO:0023051 | regulation of signaling | 18.03% (22/122) | 1.21 | 0.000174 | 0.001527 |
GO:0007017 | microtubule-based process | 8.2% (10/122) | 2.03 | 0.000182 | 0.001597 |
GO:0022414 | reproductive process | 31.15% (38/122) | 0.82 | 0.000187 | 0.001629 |
GO:0031399 | regulation of protein modification process | 9.84% (12/122) | 1.79 | 0.000197 | 0.001706 |
GO:0044788 | modulation by host of viral process | 2.46% (3/122) | 4.74 | 0.000196 | 0.00171 |
GO:0043657 | host cell | 1.64% (2/122) | 6.52 | 0.000201 | 0.001715 |
GO:0008469 | histone-arginine N-methyltransferase activity | 1.64% (2/122) | 6.52 | 0.000201 | 0.001715 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 1.64% (2/122) | 6.52 | 0.000201 | 0.001715 |
GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity | 1.64% (2/122) | 6.52 | 0.000201 | 0.001715 |
GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane | 1.64% (2/122) | 6.52 | 0.000201 | 0.001715 |
GO:0031329 | regulation of cellular catabolic process | 8.2% (10/122) | 2.01 | 0.000204 | 0.001735 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 4.1% (5/122) | 3.19 | 0.000231 | 0.001951 |
GO:0022626 | cytosolic ribosome | 4.1% (5/122) | 3.19 | 0.000231 | 0.001951 |
GO:0032879 | regulation of localization | 13.11% (16/122) | 1.45 | 0.000246 | 0.002075 |
GO:0050920 | regulation of chemotaxis | 3.28% (4/122) | 3.72 | 0.00025 | 0.002096 |
GO:0090083 | regulation of inclusion body assembly | 2.46% (3/122) | 4.62 | 0.00025 | 0.002099 |
GO:0001514 | selenocysteine incorporation | 1.64% (2/122) | 6.32 | 0.000267 | 0.002212 |
GO:0006451 | translational readthrough | 1.64% (2/122) | 6.32 | 0.000267 | 0.002212 |
GO:0031906 | late endosome lumen | 1.64% (2/122) | 6.32 | 0.000267 | 0.002212 |
GO:1904592 | positive regulation of protein refolding | 1.64% (2/122) | 6.32 | 0.000267 | 0.002212 |
GO:0001558 | regulation of cell growth | 8.2% (10/122) | 1.96 | 0.000271 | 0.002236 |
GO:2001233 | regulation of apoptotic signaling pathway | 4.1% (5/122) | 3.14 | 0.000276 | 0.002274 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 4.1% (5/122) | 3.13 | 0.000284 | 0.002325 |
GO:0097525 | spliceosomal snRNP complex | 3.28% (4/122) | 3.67 | 0.000292 | 0.002387 |
GO:0001817 | regulation of cytokine production | 4.1% (5/122) | 3.11 | 0.000298 | 0.00243 |
GO:0051641 | cellular localization | 14.75% (18/122) | 1.32 | 0.000299 | 0.00243 |
GO:0004521 | endoribonuclease activity | 3.28% (4/122) | 3.65 | 0.000303 | 0.002456 |
GO:0050767 | regulation of neurogenesis | 4.1% (5/122) | 3.1 | 0.000313 | 0.002515 |
GO:0050657 | nucleic acid transport | 4.1% (5/122) | 3.1 | 0.000313 | 0.002515 |
GO:0050658 | RNA transport | 4.1% (5/122) | 3.1 | 0.000313 | 0.002515 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 4.1% (5/122) | 3.09 | 0.000321 | 0.002562 |
GO:0051236 | establishment of RNA localization | 4.1% (5/122) | 3.09 | 0.000321 | 0.002562 |
GO:0050793 | regulation of developmental process | 22.13% (27/122) | 1.0 | 0.000322 | 0.002562 |
GO:1901796 | regulation of signal transduction by p53 class mediator | 3.28% (4/122) | 3.62 | 0.000326 | 0.002582 |
GO:0051084 | 'de novo' post-translational protein folding | 3.28% (4/122) | 3.62 | 0.000326 | 0.002582 |
GO:0099522 | cytosolic region | 2.46% (3/122) | 4.48 | 0.000334 | 0.002636 |
GO:0075733 | intracellular transport of virus | 1.64% (2/122) | 6.15 | 0.000343 | 0.002681 |
GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy | 1.64% (2/122) | 6.15 | 0.000343 | 0.002681 |
GO:0051241 | negative regulation of multicellular organismal process | 9.02% (11/122) | 1.8 | 0.000342 | 0.002688 |
GO:0140535 | intracellular protein-containing complex | 9.02% (11/122) | 1.8 | 0.00035 | 0.002732 |
GO:0031072 | heat shock protein binding | 4.1% (5/122) | 3.06 | 0.000353 | 0.00274 |
GO:1902531 | regulation of intracellular signal transduction | 9.02% (11/122) | 1.79 | 0.000353 | 0.002747 |
GO:0140098 | catalytic activity, acting on RNA | 7.38% (9/122) | 2.04 | 0.000364 | 0.002808 |
GO:0006458 | 'de novo' protein folding | 3.28% (4/122) | 3.58 | 0.000364 | 0.002812 |
GO:0010883 | regulation of lipid storage | 2.46% (3/122) | 4.42 | 0.000382 | 0.002932 |
GO:0000245 | spliceosomal complex assembly | 2.46% (3/122) | 4.42 | 0.000382 | 0.002932 |
GO:0035246 | peptidyl-arginine N-methylation | 1.64% (2/122) | 6.0 | 0.000428 | 0.003162 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 1.64% (2/122) | 6.0 | 0.000428 | 0.003162 |
GO:0031686 | A1 adenosine receptor binding | 1.64% (2/122) | 6.0 | 0.000428 | 0.003162 |
GO:0097213 | regulation of lysosomal membrane permeability | 1.64% (2/122) | 6.0 | 0.000428 | 0.003162 |
GO:0097214 | positive regulation of lysosomal membrane permeability | 1.64% (2/122) | 6.0 | 0.000428 | 0.003162 |
GO:1904593 | prostaglandin binding | 1.64% (2/122) | 6.0 | 0.000428 | 0.003162 |
GO:1904764 | chaperone-mediated autophagy translocation complex disassembly | 1.64% (2/122) | 6.0 | 0.000428 | 0.003162 |
GO:1990718 | axonemal central pair projection | 1.64% (2/122) | 6.0 | 0.000428 | 0.003162 |
GO:1990832 | slow axonal transport | 1.64% (2/122) | 6.0 | 0.000428 | 0.003162 |
GO:1990833 | clathrin-uncoating ATPase activity | 1.64% (2/122) | 6.0 | 0.000428 | 0.003162 |
GO:1990836 | lysosomal matrix | 1.64% (2/122) | 6.0 | 0.000428 | 0.003162 |
GO:1902416 | positive regulation of mRNA binding | 1.64% (2/122) | 6.0 | 0.000428 | 0.003162 |
GO:0016887 | ATP hydrolysis activity | 3.28% (4/122) | 3.52 | 0.000433 | 0.003188 |
GO:0030532 | small nuclear ribonucleoprotein complex | 3.28% (4/122) | 3.53 | 0.000418 | 0.003195 |
GO:1902903 | regulation of supramolecular fiber organization | 4.1% (5/122) | 2.99 | 0.000446 | 0.003276 |
GO:0006376 | mRNA splice site selection | 2.46% (3/122) | 4.32 | 0.000463 | 0.003377 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 2.46% (3/122) | 4.32 | 0.000463 | 0.003377 |
GO:0120114 | Sm-like protein family complex | 3.28% (4/122) | 3.49 | 0.000462 | 0.003391 |
GO:0051130 | positive regulation of cellular component organization | 7.38% (9/122) | 1.97 | 0.000522 | 0.003749 |
GO:0015931 | nucleobase-containing compound transport | 4.92% (6/122) | 2.59 | 0.000524 | 0.003751 |
GO:0016273 | arginine N-methyltransferase activity | 1.64% (2/122) | 5.86 | 0.000522 | 0.003754 |
GO:0016274 | protein-arginine N-methyltransferase activity | 1.64% (2/122) | 5.86 | 0.000522 | 0.003754 |
GO:0098690 | glycinergic synapse | 1.64% (2/122) | 5.86 | 0.000522 | 0.003754 |
GO:0098880 | maintenance of postsynaptic specialization structure | 1.64% (2/122) | 5.86 | 0.000522 | 0.003754 |
GO:0099558 | maintenance of synapse structure | 1.64% (2/122) | 5.86 | 0.000522 | 0.003754 |
GO:0001819 | positive regulation of cytokine production | 3.28% (4/122) | 3.44 | 0.000527 | 0.00376 |
GO:0008285 | negative regulation of cell population proliferation | 4.92% (6/122) | 2.57 | 0.00055 | 0.003918 |
GO:0010594 | regulation of endothelial cell migration | 2.46% (3/122) | 4.24 | 0.000554 | 0.003932 |
GO:0043066 | negative regulation of apoptotic process | 5.74% (7/122) | 2.31 | 0.000557 | 0.003946 |
GO:0010564 | regulation of cell cycle process | 7.38% (9/122) | 1.95 | 0.000575 | 0.004062 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 13.93% (17/122) | 1.29 | 0.00058 | 0.004089 |
GO:0000027 | ribosomal large subunit assembly | 2.46% (3/122) | 4.21 | 0.000586 | 0.004109 |
GO:0001671 | ATPase activator activity | 2.46% (3/122) | 4.21 | 0.000586 | 0.004109 |
GO:0009141 | nucleoside triphosphate metabolic process | 4.1% (5/122) | 2.9 | 0.000591 | 0.004133 |
GO:0080135 | regulation of cellular response to stress | 7.38% (9/122) | 1.94 | 0.000597 | 0.004165 |
GO:1903902 | positive regulation of viral life cycle | 1.64% (2/122) | 5.74 | 0.000625 | 0.004257 |
GO:0034969 | histone arginine methylation | 1.64% (2/122) | 5.74 | 0.000625 | 0.004257 |
GO:0001916 | positive regulation of T cell mediated cytotoxicity | 1.64% (2/122) | 5.74 | 0.000625 | 0.004257 |
GO:0031685 | adenosine receptor binding | 1.64% (2/122) | 5.74 | 0.000625 | 0.004257 |
GO:0071211 | protein targeting to vacuole involved in autophagy | 1.64% (2/122) | 5.74 | 0.000625 | 0.004257 |
GO:0097106 | postsynaptic density organization | 1.64% (2/122) | 5.74 | 0.000625 | 0.004257 |
GO:0099084 | postsynaptic specialization organization | 1.64% (2/122) | 5.74 | 0.000625 | 0.004257 |
GO:0099634 | postsynaptic specialization membrane | 1.64% (2/122) | 5.74 | 0.000625 | 0.004257 |
GO:1902415 | regulation of mRNA binding | 1.64% (2/122) | 5.74 | 0.000625 | 0.004257 |
GO:0051960 | regulation of nervous system development | 4.1% (5/122) | 2.88 | 0.000629 | 0.004277 |
GO:0045892 | negative regulation of DNA-templated transcription | 9.84% (12/122) | 1.59 | 0.000667 | 0.004522 |
GO:0008094 | ATP-dependent activity, acting on DNA | 4.1% (5/122) | 2.84 | 0.000697 | 0.004713 |
GO:1902679 | negative regulation of RNA biosynthetic process | 9.84% (12/122) | 1.58 | 0.000714 | 0.004803 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 9.84% (12/122) | 1.58 | 0.000714 | 0.004803 |
GO:0001914 | regulation of T cell mediated cytotoxicity | 1.64% (2/122) | 5.62 | 0.000737 | 0.004897 |
GO:0031904 | endosome lumen | 1.64% (2/122) | 5.62 | 0.000737 | 0.004897 |
GO:0140545 | ATP-dependent protein disaggregase activity | 1.64% (2/122) | 5.62 | 0.000737 | 0.004897 |
GO:1903334 | positive regulation of protein folding | 1.64% (2/122) | 5.62 | 0.000737 | 0.004897 |
GO:0000055 | ribosomal large subunit export from nucleus | 1.64% (2/122) | 5.62 | 0.000737 | 0.004897 |
GO:0050790 | regulation of catalytic activity | 9.84% (12/122) | 1.57 | 0.000748 | 0.004961 |
GO:0051338 | regulation of transferase activity | 5.74% (7/122) | 2.24 | 0.000765 | 0.005057 |
GO:0010445 | nuclear dicing body | 1.64% (2/122) | 5.52 | 0.000858 | 0.005605 |
GO:0002709 | regulation of T cell mediated immunity | 1.64% (2/122) | 5.52 | 0.000858 | 0.005605 |
GO:0002711 | positive regulation of T cell mediated immunity | 1.64% (2/122) | 5.52 | 0.000858 | 0.005605 |
GO:0061738 | late endosomal microautophagy | 1.64% (2/122) | 5.52 | 0.000858 | 0.005605 |
GO:1905216 | positive regulation of RNA binding | 1.64% (2/122) | 5.52 | 0.000858 | 0.005605 |
GO:0000966 | RNA 5'-end processing | 2.46% (3/122) | 4.0 | 0.000892 | 0.005796 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.46% (3/122) | 4.0 | 0.000892 | 0.005796 |
GO:0045824 | negative regulation of innate immune response | 3.28% (4/122) | 3.24 | 0.000896 | 0.005814 |
GO:0042470 | melanosome | 2.46% (3/122) | 3.95 | 0.000981 | 0.006346 |
GO:0018216 | peptidyl-arginine methylation | 1.64% (2/122) | 5.42 | 0.000988 | 0.006376 |
GO:0030522 | intracellular receptor signaling pathway | 3.28% (4/122) | 3.19 | 0.000998 | 0.006428 |
GO:0043085 | positive regulation of catalytic activity | 5.74% (7/122) | 2.16 | 0.001029 | 0.00661 |
GO:0019899 | enzyme binding | 13.11% (16/122) | 1.26 | 0.001049 | 0.006725 |
GO:0031330 | negative regulation of cellular catabolic process | 4.1% (5/122) | 2.7 | 0.00108 | 0.006908 |
GO:0030688 | preribosome, small subunit precursor | 1.64% (2/122) | 5.32 | 0.001127 | 0.007102 |
GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 1.64% (2/122) | 5.32 | 0.001127 | 0.007102 |
GO:0031343 | positive regulation of cell killing | 1.64% (2/122) | 5.32 | 0.001127 | 0.007102 |
GO:0002183 | cytoplasmic translational initiation | 1.64% (2/122) | 5.32 | 0.001127 | 0.007102 |
GO:1905214 | regulation of RNA binding | 1.64% (2/122) | 5.32 | 0.001127 | 0.007102 |
GO:0044093 | positive regulation of molecular function | 7.38% (9/122) | 1.81 | 0.001136 | 0.007147 |
GO:0048026 | positive regulation of mRNA splicing, via spliceosome | 2.46% (3/122) | 3.89 | 0.001125 | 0.007176 |
GO:0006996 | organelle organization | 16.39% (20/122) | 1.07 | 0.001203 | 0.007547 |
GO:0005092 | GDP-dissociation inhibitor activity | 1.64% (2/122) | 5.24 | 0.001274 | 0.007886 |
GO:0090069 | regulation of ribosome biogenesis | 1.64% (2/122) | 5.24 | 0.001274 | 0.007886 |
GO:0018195 | peptidyl-arginine modification | 1.64% (2/122) | 5.24 | 0.001274 | 0.007886 |
GO:0016191 | synaptic vesicle uncoating | 1.64% (2/122) | 5.24 | 0.001274 | 0.007886 |
GO:0045947 | negative regulation of translational initiation | 1.64% (2/122) | 5.24 | 0.001274 | 0.007886 |
GO:0048770 | pigment granule | 2.46% (3/122) | 3.82 | 0.001282 | 0.007916 |
GO:0010638 | positive regulation of organelle organization | 4.92% (6/122) | 2.34 | 0.001273 | 0.00797 |
GO:0016787 | hydrolase activity | 19.67% (24/122) | 0.94 | 0.001313 | 0.008089 |
GO:0140677 | molecular function activator activity | 2.46% (3/122) | 3.8 | 0.001337 | 0.00822 |
GO:0051094 | positive regulation of developmental process | 9.84% (12/122) | 1.47 | 0.001389 | 0.008496 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 3.28% (4/122) | 3.07 | 0.001386 | 0.008496 |
GO:0044183 | protein folding chaperone | 2.46% (3/122) | 3.78 | 0.001394 | 0.00851 |
GO:0034708 | methyltransferase complex | 3.28% (4/122) | 3.06 | 0.001419 | 0.008643 |
GO:0048870 | cell motility | 4.1% (5/122) | 2.61 | 0.001427 | 0.008671 |
GO:0031400 | negative regulation of protein modification process | 4.92% (6/122) | 2.31 | 0.001434 | 0.008674 |
GO:0043198 | dendritic shaft | 1.64% (2/122) | 5.15 | 0.001431 | 0.008674 |
GO:0007613 | memory | 2.46% (3/122) | 3.76 | 0.001452 | 0.008766 |
GO:0043167 | ion binding | 29.51% (36/122) | 0.7 | 0.001481 | 0.008916 |
GO:0043069 | negative regulation of programmed cell death | 5.74% (7/122) | 2.07 | 0.001498 | 0.009003 |
GO:0140657 | ATP-dependent activity | 7.38% (9/122) | 1.75 | 0.001526 | 0.009147 |
GO:0048585 | negative regulation of response to stimulus | 13.11% (16/122) | 1.2 | 0.00154 | 0.009212 |
GO:0006357 | regulation of transcription by RNA polymerase II | 9.84% (12/122) | 1.45 | 0.001556 | 0.009289 |
GO:0008139 | nuclear localization sequence binding | 1.64% (2/122) | 5.08 | 0.001596 | 0.009339 |
GO:0030682 | mitigation of host defenses by symbiont | 1.64% (2/122) | 5.08 | 0.001596 | 0.009339 |
GO:0061608 | nuclear import signal receptor activity | 1.64% (2/122) | 5.08 | 0.001596 | 0.009339 |
GO:0009097 | isoleucine biosynthetic process | 1.64% (2/122) | 5.08 | 0.001596 | 0.009339 |
GO:0001910 | regulation of leukocyte mediated cytotoxicity | 1.64% (2/122) | 5.08 | 0.001596 | 0.009339 |
GO:0044829 | positive regulation by host of viral genome replication | 1.64% (2/122) | 5.08 | 0.001596 | 0.009339 |
GO:0072318 | clathrin coat disassembly | 1.64% (2/122) | 5.08 | 0.001596 | 0.009339 |
GO:0050685 | positive regulation of mRNA processing | 2.46% (3/122) | 3.72 | 0.001573 | 0.00937 |
GO:0051053 | negative regulation of DNA metabolic process | 3.28% (4/122) | 3.01 | 0.001595 | 0.009481 |
GO:1902905 | positive regulation of supramolecular fiber organization | 2.46% (3/122) | 3.7 | 0.001636 | 0.009534 |
GO:0000049 | tRNA binding | 2.46% (3/122) | 3.7 | 0.001636 | 0.009534 |
GO:0031983 | vesicle lumen | 2.46% (3/122) | 3.68 | 0.0017 | 0.009824 |
GO:0034774 | secretory granule lumen | 2.46% (3/122) | 3.68 | 0.0017 | 0.009824 |
GO:0060205 | cytoplasmic vesicle lumen | 2.46% (3/122) | 3.68 | 0.0017 | 0.009824 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 7.38% (9/122) | 1.72 | 0.001717 | 0.009875 |
GO:0009896 | positive regulation of catabolic process | 5.74% (7/122) | 2.04 | 0.001699 | 0.009878 |
GO:0051052 | regulation of DNA metabolic process | 5.74% (7/122) | 2.03 | 0.001716 | 0.009895 |
GO:0005080 | protein kinase C binding | 1.64% (2/122) | 5.0 | 0.001769 | 0.010072 |
GO:0010665 | regulation of cardiac muscle cell apoptotic process | 1.64% (2/122) | 5.0 | 0.001769 | 0.010072 |
GO:0010667 | negative regulation of cardiac muscle cell apoptotic process | 1.64% (2/122) | 5.0 | 0.001769 | 0.010072 |
GO:0032570 | response to progesterone | 1.64% (2/122) | 5.0 | 0.001769 | 0.010072 |
GO:0002832 | negative regulation of response to biotic stimulus | 4.92% (6/122) | 2.25 | 0.001757 | 0.010086 |
GO:0045596 | negative regulation of cell differentiation | 4.1% (5/122) | 2.54 | 0.001792 | 0.010179 |
GO:0004540 | ribonuclease activity | 3.28% (4/122) | 2.96 | 0.001827 | 0.010353 |
GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 2.46% (3/122) | 3.64 | 0.001834 | 0.010372 |
GO:0060284 | regulation of cell development | 4.1% (5/122) | 2.53 | 0.001849 | 0.010438 |
GO:0001664 | G protein-coupled receptor binding | 2.46% (3/122) | 3.62 | 0.001903 | 0.010695 |
GO:0008134 | transcription factor binding | 5.74% (7/122) | 2.01 | 0.0019 | 0.010704 |
GO:0030955 | potassium ion binding | 1.64% (2/122) | 4.93 | 0.001952 | 0.010948 |
GO:0030544 | Hsp70 protein binding | 2.46% (3/122) | 3.6 | 0.001973 | 0.011046 |
GO:0070727 | cellular macromolecule localization | 11.48% (14/122) | 1.27 | 0.002 | 0.011171 |
GO:0031974 | membrane-enclosed lumen | 7.38% (9/122) | 1.69 | 0.002046 | 0.011313 |
GO:0043233 | organelle lumen | 7.38% (9/122) | 1.69 | 0.002046 | 0.011313 |
GO:0070013 | intracellular organelle lumen | 7.38% (9/122) | 1.69 | 0.002046 | 0.011313 |
GO:0033036 | macromolecule localization | 12.3% (15/122) | 1.21 | 0.002036 | 0.011347 |
GO:0004386 | helicase activity | 4.1% (5/122) | 2.49 | 0.00206 | 0.011367 |
GO:0043462 | regulation of ATP-dependent activity | 2.46% (3/122) | 3.59 | 0.002046 | 0.01138 |
GO:0051569 | regulation of histone H3-K4 methylation | 2.46% (3/122) | 3.57 | 0.00212 | 0.01167 |
GO:0098684 | photoreceptor ribbon synapse | 1.64% (2/122) | 4.86 | 0.002143 | 0.011773 |
GO:0008104 | protein localization | 10.66% (13/122) | 1.32 | 0.002177 | 0.011937 |
GO:0048856 | anatomical structure development | 31.15% (38/122) | 0.64 | 0.002218 | 0.012138 |
GO:0044089 | positive regulation of cellular component biogenesis | 4.1% (5/122) | 2.46 | 0.002255 | 0.012313 |
GO:0052173 | response to defenses of other organism | 1.64% (2/122) | 4.8 | 0.002342 | 0.012536 |
GO:0052200 | response to host defenses | 1.64% (2/122) | 4.8 | 0.002342 | 0.012536 |
GO:0075136 | response to host | 1.64% (2/122) | 4.8 | 0.002342 | 0.012536 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.64% (2/122) | 4.8 | 0.002342 | 0.012536 |
GO:0034331 | cell junction maintenance | 1.64% (2/122) | 4.8 | 0.002342 | 0.012536 |
GO:0097212 | lysosomal membrane organization | 1.64% (2/122) | 4.8 | 0.002342 | 0.012536 |
GO:0009068 | aspartate family amino acid catabolic process | 1.64% (2/122) | 4.8 | 0.002342 | 0.012536 |
GO:0031597 | cytosolic proteasome complex | 1.64% (2/122) | 4.8 | 0.002342 | 0.012536 |
GO:0014069 | postsynaptic density | 3.28% (4/122) | 2.86 | 0.002309 | 0.012558 |
GO:0099572 | postsynaptic specialization | 3.28% (4/122) | 2.86 | 0.002309 | 0.012558 |
GO:0033120 | positive regulation of RNA splicing | 2.46% (3/122) | 3.5 | 0.002432 | 0.012991 |
GO:0000075 | cell cycle checkpoint signaling | 3.28% (4/122) | 2.84 | 0.002454 | 0.013084 |
GO:0043067 | regulation of programmed cell death | 8.2% (10/122) | 1.54 | 0.002474 | 0.013166 |
GO:0042802 | identical protein binding | 15.57% (19/122) | 1.02 | 0.002502 | 0.013289 |
GO:0006622 | protein targeting to lysosome | 1.64% (2/122) | 4.74 | 0.002549 | 0.01333 |
GO:0010662 | regulation of striated muscle cell apoptotic process | 1.64% (2/122) | 4.74 | 0.002549 | 0.01333 |
GO:0010664 | negative regulation of striated muscle cell apoptotic process | 1.64% (2/122) | 4.74 | 0.002549 | 0.01333 |
GO:0030864 | cortical actin cytoskeleton | 1.64% (2/122) | 4.74 | 0.002549 | 0.01333 |
GO:0043954 | cellular component maintenance | 1.64% (2/122) | 4.74 | 0.002549 | 0.01333 |
GO:0061635 | regulation of protein complex stability | 1.64% (2/122) | 4.74 | 0.002549 | 0.01333 |
GO:0035578 | azurophil granule lumen | 1.64% (2/122) | 4.74 | 0.002549 | 0.01333 |
GO:0048513 | animal organ development | 8.2% (10/122) | 1.53 | 0.002523 | 0.013372 |
GO:0018995 | host cellular component | 2.46% (3/122) | 3.47 | 0.002598 | 0.01353 |
GO:0035196 | miRNA processing | 2.46% (3/122) | 3.47 | 0.002598 | 0.01353 |
GO:0032102 | negative regulation of response to external stimulus | 4.92% (6/122) | 2.12 | 0.002714 | 0.014109 |
GO:0031420 | alkali metal ion binding | 1.64% (2/122) | 4.68 | 0.002766 | 0.014158 |
GO:0010045 | response to nickel cation | 1.64% (2/122) | 4.68 | 0.002766 | 0.014158 |
GO:0044794 | positive regulation by host of viral process | 1.64% (2/122) | 4.68 | 0.002766 | 0.014158 |
GO:0072319 | vesicle uncoating | 1.64% (2/122) | 4.68 | 0.002766 | 0.014158 |
GO:0099524 | postsynaptic cytosol | 1.64% (2/122) | 4.68 | 0.002766 | 0.014158 |
GO:1901567 | fatty acid derivative binding | 1.64% (2/122) | 4.68 | 0.002766 | 0.014158 |
GO:1905710 | positive regulation of membrane permeability | 1.64% (2/122) | 4.68 | 0.002766 | 0.014158 |
GO:0048731 | system development | 8.2% (10/122) | 1.52 | 0.002743 | 0.014229 |
GO:0010941 | regulation of cell death | 9.02% (11/122) | 1.42 | 0.002801 | 0.014314 |
GO:0051495 | positive regulation of cytoskeleton organization | 2.46% (3/122) | 3.42 | 0.00286 | 0.014585 |
GO:0006355 | regulation of DNA-templated transcription | 17.21% (21/122) | 0.94 | 0.002866 | 0.014591 |
GO:0034645 | cellular macromolecule biosynthetic process | 7.38% (9/122) | 1.61 | 0.002897 | 0.014721 |
GO:2000026 | regulation of multicellular organismal development | 12.3% (15/122) | 1.16 | 0.00292 | 0.01478 |
GO:0006402 | mRNA catabolic process | 3.28% (4/122) | 2.77 | 0.002927 | 0.01479 |
GO:0071705 | nitrogen compound transport | 11.48% (14/122) | 1.21 | 0.00292 | 0.014806 |
GO:0002020 | protease binding | 2.46% (3/122) | 3.4 | 0.00295 | 0.014879 |
GO:0140142 | nucleocytoplasmic carrier activity | 1.64% (2/122) | 4.62 | 0.00299 | 0.014883 |
GO:0006549 | isoleucine metabolic process | 1.64% (2/122) | 4.62 | 0.00299 | 0.014883 |
GO:0061083 | regulation of protein refolding | 1.64% (2/122) | 4.62 | 0.00299 | 0.014883 |
GO:0097470 | ribbon synapse | 1.64% (2/122) | 4.62 | 0.00299 | 0.014883 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 1.64% (2/122) | 4.62 | 0.00299 | 0.014883 |
GO:1903506 | regulation of nucleic acid-templated transcription | 17.21% (21/122) | 0.93 | 0.002964 | 0.014921 |
GO:2001141 | regulation of RNA biosynthetic process | 17.21% (21/122) | 0.93 | 0.002984 | 0.014994 |
GO:0043549 | regulation of kinase activity | 4.1% (5/122) | 2.35 | 0.003125 | 0.015001 |
GO:0007315 | pole plasm assembly | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:1904990 | regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:1904992 | positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:0033098 | amyloplast inner membrane | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:0060258 | negative regulation of filamentous growth | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:0060853 | Notch signaling pathway involved in arterial endothelial cell fate commitment | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:0070785 | negative regulation of growth of unicellular organism as a thread of attached cells | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:1900429 | negative regulation of filamentous growth of a population of unicellular organisms | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:1902974 | meiotic DNA replication initiation | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:2000220 | regulation of pseudohyphal growth | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:2000221 | negative regulation of pseudohyphal growth | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:0004777 | succinate-semialdehyde dehydrogenase (NAD+) activity | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:0006540 | glutamate decarboxylation to succinate | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:0009013 | succinate-semialdehyde dehydrogenase [NAD(P)+] activity | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:0036243 | succinate-semialdehyde dehydrogenase (NADP+) activity | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:0047949 | glutarate-semialdehyde dehydrogenase (NAD+) activity | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:0102810 | glutarate-semialdehyde dehydrogenase (NADP+) activity | 0.82% (1/122) | 8.32 | 0.003121 | 0.015011 |
GO:0006805 | xenobiotic metabolic process | 2.46% (3/122) | 3.39 | 0.003043 | 0.01512 |
GO:2000232 | regulation of rRNA processing | 1.64% (2/122) | 4.57 | 0.003223 | 0.015388 |
GO:0001824 | blastocyst development | 1.64% (2/122) | 4.57 | 0.003223 | 0.015388 |
GO:0010656 | negative regulation of muscle cell apoptotic process | 1.64% (2/122) | 4.57 | 0.003223 | 0.015388 |
GO:0048167 | regulation of synaptic plasticity | 2.46% (3/122) | 3.35 | 0.003234 | 0.015414 |
GO:0033365 | protein localization to organelle | 6.56% (8/122) | 1.71 | 0.003309 | 0.015745 |
GO:0007612 | learning | 2.46% (3/122) | 3.32 | 0.003431 | 0.016269 |
GO:0005096 | GTPase activator activity | 2.46% (3/122) | 3.32 | 0.003431 | 0.016269 |
GO:0000076 | DNA replication checkpoint signaling | 1.64% (2/122) | 4.52 | 0.003463 | 0.016336 |
GO:0001786 | phosphatidylserine binding | 1.64% (2/122) | 4.52 | 0.003463 | 0.016336 |
GO:0030308 | negative regulation of cell growth | 3.28% (4/122) | 2.7 | 0.00346 | 0.016376 |
GO:0006412 | translation | 4.92% (6/122) | 2.05 | 0.00348 | 0.016384 |
GO:0046907 | intracellular transport | 9.02% (11/122) | 1.38 | 0.003514 | 0.016518 |
GO:0005840 | ribosome | 4.92% (6/122) | 2.04 | 0.003553 | 0.016672 |
GO:0007165 | signal transduction | 18.85% (23/122) | 0.85 | 0.003608 | 0.016899 |
GO:0050777 | negative regulation of immune response | 3.28% (4/122) | 2.68 | 0.003651 | 0.017042 |
GO:0018130 | heterocycle biosynthetic process | 10.66% (13/122) | 1.23 | 0.003651 | 0.01707 |
GO:2000765 | regulation of cytoplasmic translation | 1.64% (2/122) | 4.47 | 0.003712 | 0.017209 |
GO:0005882 | intermediate filament | 1.64% (2/122) | 4.47 | 0.003712 | 0.017209 |
GO:0036260 | RNA capping | 1.64% (2/122) | 4.47 | 0.003712 | 0.017209 |
GO:0009895 | negative regulation of catabolic process | 4.1% (5/122) | 2.29 | 0.003712 | 0.017297 |
GO:0051085 | chaperone cofactor-dependent protein refolding | 2.46% (3/122) | 3.26 | 0.003848 | 0.017748 |
GO:0006986 | response to unfolded protein | 2.46% (3/122) | 3.26 | 0.003848 | 0.017748 |
GO:0016363 | nuclear matrix | 2.46% (3/122) | 3.26 | 0.003848 | 0.017748 |
GO:0030174 | regulation of DNA-templated DNA replication initiation | 1.64% (2/122) | 4.42 | 0.003969 | 0.018213 |
GO:0044827 | modulation by host of viral genome replication | 1.64% (2/122) | 4.42 | 0.003969 | 0.018213 |
GO:1990124 | messenger ribonucleoprotein complex | 1.64% (2/122) | 4.42 | 0.003969 | 0.018213 |
GO:0006351 | DNA-templated transcription | 3.28% (4/122) | 2.64 | 0.003985 | 0.018255 |
GO:2000243 | positive regulation of reproductive process | 4.92% (6/122) | 2.0 | 0.004141 | 0.018937 |
GO:0016578 | histone deubiquitination | 1.64% (2/122) | 4.37 | 0.004235 | 0.019331 |
GO:0031396 | regulation of protein ubiquitination | 3.28% (4/122) | 2.62 | 0.004267 | 0.019448 |
GO:0010632 | regulation of epithelial cell migration | 2.46% (3/122) | 3.21 | 0.004295 | 0.019541 |
GO:0000785 | chromatin | 4.92% (6/122) | 1.98 | 0.00431 | 0.019574 |
GO:0060548 | negative regulation of cell death | 5.74% (7/122) | 1.79 | 0.00433 | 0.019634 |
GO:0097659 | nucleic acid-templated transcription | 3.28% (4/122) | 2.61 | 0.00434 | 0.019646 |
GO:1905952 | regulation of lipid localization | 2.46% (3/122) | 3.19 | 0.004411 | 0.019869 |
GO:1903312 | negative regulation of mRNA metabolic process | 2.46% (3/122) | 3.19 | 0.004411 | 0.019869 |
GO:0030490 | maturation of SSU-rRNA | 2.46% (3/122) | 3.19 | 0.004411 | 0.019869 |
GO:0048598 | embryonic morphogenesis | 4.1% (5/122) | 2.23 | 0.004429 | 0.019915 |
GO:0009299 | mRNA transcription | 1.64% (2/122) | 4.32 | 0.004508 | 0.020135 |
GO:0110020 | regulation of actomyosin structure organization | 1.64% (2/122) | 4.32 | 0.004508 | 0.020135 |
GO:0045580 | regulation of T cell differentiation | 1.64% (2/122) | 4.32 | 0.004508 | 0.020135 |
GO:0090559 | regulation of membrane permeability | 1.64% (2/122) | 4.32 | 0.004508 | 0.020135 |
GO:0009066 | aspartate family amino acid metabolic process | 2.46% (3/122) | 3.18 | 0.00453 | 0.020199 |
GO:0043043 | peptide biosynthetic process | 4.92% (6/122) | 1.96 | 0.004616 | 0.020552 |
GO:0070201 | regulation of establishment of protein localization | 4.1% (5/122) | 2.21 | 0.004707 | 0.020923 |
GO:0019079 | viral genome replication | 1.64% (2/122) | 4.28 | 0.004789 | 0.021111 |
GO:0031112 | positive regulation of microtubule polymerization or depolymerization | 1.64% (2/122) | 4.28 | 0.004789 | 0.021111 |
GO:0008097 | 5S rRNA binding | 1.64% (2/122) | 4.28 | 0.004789 | 0.021111 |
GO:0033290 | eukaryotic 48S preinitiation complex | 1.64% (2/122) | 4.28 | 0.004789 | 0.021111 |
GO:0140694 | non-membrane-bounded organelle assembly | 4.1% (5/122) | 2.21 | 0.004764 | 0.021142 |
GO:0043065 | positive regulation of apoptotic process | 3.28% (4/122) | 2.56 | 0.00495 | 0.021788 |
GO:0009082 | branched-chain amino acid biosynthetic process | 1.64% (2/122) | 4.24 | 0.005078 | 0.022203 |
GO:0031341 | regulation of cell killing | 1.64% (2/122) | 4.24 | 0.005078 | 0.022203 |
GO:0061462 | protein localization to lysosome | 1.64% (2/122) | 4.24 | 0.005078 | 0.022203 |
GO:0140776 | protein-containing complex destabilizing activity | 1.64% (2/122) | 4.24 | 0.005078 | 0.022203 |
GO:1901988 | negative regulation of cell cycle phase transition | 3.28% (4/122) | 2.54 | 0.005111 | 0.022279 |
GO:0051254 | positive regulation of RNA metabolic process | 11.48% (14/122) | 1.12 | 0.005111 | 0.022311 |
GO:1903332 | regulation of protein folding | 1.64% (2/122) | 4.19 | 0.005374 | 0.023388 |
GO:0051301 | cell division | 5.74% (7/122) | 1.73 | 0.005388 | 0.02341 |
GO:0000278 | mitotic cell cycle | 2.46% (3/122) | 3.09 | 0.005411 | 0.023434 |
GO:2001242 | regulation of intrinsic apoptotic signaling pathway | 2.46% (3/122) | 3.09 | 0.005411 | 0.023434 |
GO:0140097 | catalytic activity, acting on DNA | 4.1% (5/122) | 2.16 | 0.005426 | 0.02346 |
GO:0007283 | spermatogenesis | 3.28% (4/122) | 2.52 | 0.005444 | 0.023502 |
GO:0010660 | regulation of muscle cell apoptotic process | 1.64% (2/122) | 4.15 | 0.005679 | 0.024476 |
GO:0050877 | nervous system process | 4.1% (5/122) | 2.14 | 0.005813 | 0.025013 |
GO:0060135 | maternal process involved in female pregnancy | 1.64% (2/122) | 4.11 | 0.005991 | 0.025699 |
GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex | 1.64% (2/122) | 4.11 | 0.005991 | 0.025699 |
GO:0043921 | modulation by host of viral transcription | 0.82% (1/122) | 7.32 | 0.006233 | 0.026193 |
GO:0004455 | ketol-acid reductoisomerase activity | 0.82% (1/122) | 7.32 | 0.006233 | 0.026193 |
GO:0007028 | cytoplasm organization | 0.82% (1/122) | 7.32 | 0.006233 | 0.026193 |
GO:0033097 | amyloplast membrane | 0.82% (1/122) | 7.32 | 0.006233 | 0.026193 |
GO:1903677 | regulation of cap-independent translational initiation | 0.82% (1/122) | 7.32 | 0.006233 | 0.026193 |
GO:1903679 | positive regulation of cap-independent translational initiation | 0.82% (1/122) | 7.32 | 0.006233 | 0.026193 |
GO:0035517 | PR-DUB complex | 0.82% (1/122) | 7.32 | 0.006233 | 0.026193 |
GO:0061519 | macrophage homeostasis | 0.82% (1/122) | 7.32 | 0.006233 | 0.026193 |
GO:0060065 | uterus development | 0.82% (1/122) | 7.32 | 0.006233 | 0.026193 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 0.82% (1/122) | 7.32 | 0.006233 | 0.026193 |
GO:0070564 | positive regulation of vitamin D receptor signaling pathway | 0.82% (1/122) | 7.32 | 0.006233 | 0.026193 |
GO:0002682 | regulation of immune system process | 9.84% (12/122) | 1.2 | 0.006124 | 0.026227 |
GO:0065008 | regulation of biological quality | 19.67% (24/122) | 0.77 | 0.006174 | 0.026397 |
GO:0030863 | cortical cytoskeleton | 1.64% (2/122) | 4.08 | 0.006311 | 0.026441 |
GO:0016282 | eukaryotic 43S preinitiation complex | 1.64% (2/122) | 4.08 | 0.006311 | 0.026441 |
GO:0090329 | regulation of DNA-templated DNA replication | 2.46% (3/122) | 3.0 | 0.006389 | 0.026725 |
GO:0009790 | embryo development | 9.02% (11/122) | 1.26 | 0.006499 | 0.027142 |
GO:0031570 | DNA integrity checkpoint signaling | 2.46% (3/122) | 2.99 | 0.006537 | 0.027217 |
GO:0006401 | RNA catabolic process | 3.28% (4/122) | 2.44 | 0.006529 | 0.027225 |
GO:1901000 | regulation of response to salt stress | 4.1% (5/122) | 2.09 | 0.006572 | 0.02728 |
GO:0043414 | macromolecule methylation | 4.1% (5/122) | 2.09 | 0.006572 | 0.02728 |
GO:0009968 | negative regulation of signal transduction | 8.2% (10/122) | 1.33 | 0.006635 | 0.027456 |
GO:0002683 | negative regulation of immune system process | 3.28% (4/122) | 2.43 | 0.006625 | 0.027457 |
GO:0010975 | regulation of neuron projection development | 3.28% (4/122) | 2.43 | 0.006722 | 0.027775 |
GO:0032104 | regulation of response to extracellular stimulus | 2.46% (3/122) | 2.97 | 0.006838 | 0.028039 |
GO:0032107 | regulation of response to nutrient levels | 2.46% (3/122) | 2.97 | 0.006838 | 0.028039 |
GO:0009911 | positive regulation of flower development | 3.28% (4/122) | 2.42 | 0.006821 | 0.028052 |
GO:0051347 | positive regulation of transferase activity | 3.28% (4/122) | 2.42 | 0.006821 | 0.028052 |
GO:0070925 | organelle assembly | 4.92% (6/122) | 1.85 | 0.006805 | 0.028074 |
GO:0007417 | central nervous system development | 1.64% (2/122) | 4.0 | 0.006974 | 0.028424 |
GO:0071277 | cellular response to calcium ion | 1.64% (2/122) | 4.0 | 0.006974 | 0.028424 |
GO:0002821 | positive regulation of adaptive immune response | 1.64% (2/122) | 4.0 | 0.006974 | 0.028424 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.64% (2/122) | 4.0 | 0.006974 | 0.028424 |
GO:0032101 | regulation of response to external stimulus | 10.66% (13/122) | 1.12 | 0.007029 | 0.028603 |
GO:0044265 | cellular macromolecule catabolic process | 7.38% (9/122) | 1.41 | 0.007087 | 0.028795 |
GO:0043005 | neuron projection | 4.92% (6/122) | 1.83 | 0.007108 | 0.02884 |
GO:0032481 | positive regulation of type I interferon production | 1.64% (2/122) | 3.97 | 0.007317 | 0.029509 |
GO:0045619 | regulation of lymphocyte differentiation | 1.64% (2/122) | 3.97 | 0.007317 | 0.029509 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 1.64% (2/122) | 3.97 | 0.007317 | 0.029509 |
GO:0043197 | dendritic spine | 1.64% (2/122) | 3.97 | 0.007317 | 0.029509 |
GO:0050896 | response to stimulus | 50.0% (61/122) | 0.37 | 0.007363 | 0.029607 |
GO:0016570 | histone modification | 4.92% (6/122) | 1.82 | 0.007358 | 0.02963 |
GO:1903320 | regulation of protein modification by small protein conjugation or removal | 3.28% (4/122) | 2.39 | 0.00743 | 0.029832 |
GO:0035097 | histone methyltransferase complex | 2.46% (3/122) | 2.92 | 0.007466 | 0.02993 |
GO:0035966 | response to topologically incorrect protein | 2.46% (3/122) | 2.91 | 0.007628 | 0.030534 |
GO:0032806 | carboxy-terminal domain protein kinase complex | 1.64% (2/122) | 3.93 | 0.007667 | 0.030647 |
GO:0007276 | gamete generation | 4.1% (5/122) | 2.04 | 0.007716 | 0.030797 |
GO:0051592 | response to calcium ion | 2.46% (3/122) | 2.89 | 0.007958 | 0.031668 |
GO:1903706 | regulation of hemopoiesis | 2.46% (3/122) | 2.89 | 0.007958 | 0.031668 |
GO:0005686 | U2 snRNP | 1.64% (2/122) | 3.9 | 0.008025 | 0.031794 |
GO:0031519 | PcG protein complex | 1.64% (2/122) | 3.9 | 0.008025 | 0.031794 |
GO:0044309 | neuron spine | 1.64% (2/122) | 3.9 | 0.008025 | 0.031794 |
GO:0007275 | multicellular organism development | 13.11% (16/122) | 0.96 | 0.008055 | 0.031864 |
GO:0023057 | negative regulation of signaling | 8.2% (10/122) | 1.29 | 0.008246 | 0.032572 |
GO:0004519 | endonuclease activity | 3.28% (4/122) | 2.34 | 0.008297 | 0.032681 |
GO:0051656 | establishment of organelle localization | 4.1% (5/122) | 2.01 | 0.008295 | 0.032719 |
GO:0010648 | negative regulation of cell communication | 8.2% (10/122) | 1.28 | 0.008329 | 0.032758 |
GO:0002706 | regulation of lymphocyte mediated immunity | 1.64% (2/122) | 3.86 | 0.00839 | 0.032854 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.64% (2/122) | 3.86 | 0.00839 | 0.032854 |
GO:0034620 | cellular response to unfolded protein | 1.64% (2/122) | 3.86 | 0.00839 | 0.032854 |
GO:0043254 | regulation of protein-containing complex assembly | 3.28% (4/122) | 2.34 | 0.00841 | 0.032885 |
GO:0070545 | PeBoW complex | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0036455 | iron-sulfur transferase activity | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0106034 | protein maturation by [2Fe-2S] cluster transfer | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0046604 | positive regulation of mitotic centrosome separation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0062029 | positive regulation of stress granule assembly | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0042118 | endothelial cell activation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0001734 | mRNA (N6-adenosine)-methyltransferase activity | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0021861 | forebrain radial glial cell differentiation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0030708 | germarium-derived female germ-line cyst encapsulation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0048139 | female germ-line cyst encapsulation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0060019 | radial glial cell differentiation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1904690 | positive regulation of cytoplasmic translational initiation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0016277 | [myelin basic protein]-arginine N-methyltransferase activity | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0035521 | monoubiquitinated histone deubiquitination | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0035522 | monoubiquitinated histone H2A deubiquitination | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0005846 | nuclear cap binding complex | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1903460 | mitotic DNA replication leading strand elongation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0051086 | chaperone mediated protein folding independent of cofactor | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0010974 | negative regulation of division septum assembly | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0021508 | floor plate formation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0031029 | regulation of septation initiation signaling | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0031031 | positive regulation of septation initiation signaling | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0031568 | mitotic G1 cell size control checkpoint signaling | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0032297 | negative regulation of DNA-templated DNA replication initiation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0048706 | embryonic skeletal system development | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0051986 | negative regulation of attachment of spindle microtubules to kinetochore | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0060629 | regulation of homologous chromosome segregation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0062123 | regulation of linear element maturation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0072410 | response to meiotic cell cycle checkpoint signaling | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0072414 | response to mitotic cell cycle checkpoint signaling | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0072417 | response to spindle checkpoint signaling | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0072426 | response to G2 DNA damage checkpoint signaling | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0072435 | response to mitotic G2 DNA damage checkpoint signaling | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0072438 | response to DNA replication checkpoint signaling | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0072441 | response to meiotic DNA replication checkpoint signaling | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0072476 | response to mitotic spindle checkpoint signaling | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0072479 | response to mitotic cell cycle spindle assembly checkpoint signaling | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0072485 | response to spindle assembly checkpoint signaling | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0090006 | regulation of linear element assembly | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0140273 | repair of mitotic kinetochore microtubule attachment defect | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0140274 | repair of kinetochore microtubule attachment defect | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0140280 | negative regulation of mitotic division septum assembly | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0140429 | positive regulation of mitotic sister chromatid biorientation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1901892 | negative regulation of cell septum assembly | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1902413 | negative regulation of mitotic cytokinesis | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1902424 | negative regulation of attachment of mitotic spindle microtubules to kinetochore | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1902576 | negative regulation of nuclear cell cycle DNA replication | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1902845 | negative regulation of mitotic spindle elongation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1903380 | positive regulation of mitotic chromosome condensation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1903437 | negative regulation of mitotic cytokinetic process | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1903464 | negative regulation of mitotic cell cycle DNA replication | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1903465 | positive regulation of mitotic cell cycle DNA replication | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1903466 | regulation of mitotic DNA replication initiation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1903467 | negative regulation of mitotic DNA replication initiation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1903500 | negative regulation of mitotic actomyosin contractile ring assembly | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1904536 | regulation of mitotic telomere tethering at nuclear periphery | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1904537 | negative regulation of mitotic telomere tethering at nuclear periphery | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1905263 | positive regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1905756 | regulation of primary cell septum biogenesis | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1905757 | negative regulation of primary cell septum biogenesis | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1905785 | negative regulation of anaphase-promoting complex-dependent catabolic process | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1905821 | positive regulation of chromosome condensation | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:1990820 | response to mitotic DNA integrity checkpoint signaling | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:2000432 | negative regulation of cytokinesis, actomyosin contractile ring assembly | 0.82% (1/122) | 6.74 | 0.009335 | 0.033051 |
GO:0030162 | regulation of proteolysis | 4.92% (6/122) | 1.74 | 0.009437 | 0.033369 |
GO:0045926 | negative regulation of growth | 4.1% (5/122) | 1.96 | 0.009542 | 0.033607 |
GO:0048577 | negative regulation of short-day photoperiodism, flowering | 1.64% (2/122) | 3.77 | 0.009529 | 0.033608 |
GO:0043195 | terminal bouton | 1.64% (2/122) | 3.77 | 0.009529 | 0.033608 |
GO:0034644 | cellular response to UV | 2.46% (3/122) | 2.84 | 0.008644 | 0.0337 |
GO:0048232 | male gamete generation | 3.28% (4/122) | 2.32 | 0.008639 | 0.03373 |
GO:0001917 | photoreceptor inner segment | 1.64% (2/122) | 3.83 | 0.008763 | 0.034017 |
GO:0002819 | regulation of adaptive immune response | 1.64% (2/122) | 3.83 | 0.008763 | 0.034017 |
GO:0006974 | cellular response to DNA damage stimulus | 6.56% (8/122) | 1.47 | 0.008751 | 0.034069 |
GO:0071014 | post-mRNA release spliceosomal complex | 1.64% (2/122) | 3.74 | 0.009924 | 0.034816 |
GO:0007601 | visual perception | 1.64% (2/122) | 3.74 | 0.009924 | 0.034816 |
GO:0051261 | protein depolymerization | 1.64% (2/122) | 3.74 | 0.009924 | 0.034816 |
GO:0045088 | regulation of innate immune response | 5.74% (7/122) | 1.56 | 0.010072 | 0.035292 |
GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding | 3.28% (4/122) | 2.26 | 0.010097 | 0.035332 |
GO:0045597 | positive regulation of cell differentiation | 4.1% (5/122) | 1.94 | 0.010211 | 0.035685 |
GO:0044092 | negative regulation of molecular function | 5.74% (7/122) | 1.55 | 0.010277 | 0.035868 |
GO:0099175 | regulation of postsynapse organization | 1.64% (2/122) | 3.71 | 0.010325 | 0.035944 |
GO:0070993 | translation preinitiation complex | 1.64% (2/122) | 3.71 | 0.010325 | 0.035944 |
GO:0042325 | regulation of phosphorylation | 4.92% (6/122) | 1.75 | 0.009286 | 0.035998 |
GO:0009150 | purine ribonucleotide metabolic process | 4.1% (5/122) | 1.93 | 0.010507 | 0.036344 |
GO:0032880 | regulation of protein localization | 4.92% (6/122) | 1.71 | 0.010456 | 0.036355 |
GO:0007093 | mitotic cell cycle checkpoint signaling | 2.46% (3/122) | 2.74 | 0.010505 | 0.036385 |
GO:0008186 | ATP-dependent activity, acting on RNA | 2.46% (3/122) | 2.74 | 0.010505 | 0.036385 |
GO:0005856 | cytoskeleton | 4.92% (6/122) | 1.71 | 0.010538 | 0.036404 |
GO:0061136 | regulation of proteasomal protein catabolic process | 3.28% (4/122) | 2.24 | 0.010485 | 0.036406 |
GO:0033554 | cellular response to stress | 16.39% (20/122) | 0.79 | 0.010616 | 0.036625 |
GO:0031110 | regulation of microtubule polymerization or depolymerization | 1.64% (2/122) | 3.68 | 0.010733 | 0.036843 |
GO:0008143 | poly(A) binding | 1.64% (2/122) | 3.68 | 0.010733 | 0.036843 |
GO:0050953 | sensory perception of light stimulus | 1.64% (2/122) | 3.68 | 0.010733 | 0.036843 |
GO:0000502 | proteasome complex | 1.64% (2/122) | 3.68 | 0.010733 | 0.036843 |
GO:0031348 | negative regulation of defense response | 4.92% (6/122) | 1.7 | 0.010869 | 0.037213 |
GO:0051649 | establishment of localization in cell | 9.02% (11/122) | 1.15 | 0.01086 | 0.037229 |
GO:0048046 | apoplast | 6.56% (8/122) | 1.41 | 0.011093 | 0.037933 |
GO:0017025 | TBP-class protein binding | 1.64% (2/122) | 3.65 | 0.011149 | 0.037979 |
GO:0006403 | RNA localization | 1.64% (2/122) | 3.65 | 0.011149 | 0.037979 |
GO:0007265 | Ras protein signal transduction | 1.64% (2/122) | 3.65 | 0.011149 | 0.037979 |
GO:0048640 | negative regulation of developmental growth | 2.46% (3/122) | 2.7 | 0.01131 | 0.038431 |
GO:0015630 | microtubule cytoskeleton | 2.46% (3/122) | 2.7 | 0.01131 | 0.038431 |
GO:0046794 | transport of virus | 1.64% (2/122) | 3.62 | 0.011571 | 0.03927 |
GO:0003006 | developmental process involved in reproduction | 22.13% (27/122) | 0.64 | 0.011787 | 0.039953 |
GO:0045182 | translation regulator activity | 3.28% (4/122) | 2.19 | 0.011847 | 0.040103 |
GO:0009266 | response to temperature stimulus | 12.3% (15/122) | 0.93 | 0.011899 | 0.040229 |
GO:0032479 | regulation of type I interferon production | 1.64% (2/122) | 3.57 | 0.012437 | 0.04038 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.64% (2/122) | 3.57 | 0.012437 | 0.04038 |
GO:0045694 | regulation of embryo sac egg cell differentiation | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:1903241 | U2-type prespliceosome assembly | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0022623 | proteasome-activating nucleotidase complex | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0047334 | diphosphate-fructose-6-phosphate 1-phosphotransferase activity | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0051674 | localization of cell | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0005642 | annulate lamellae | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0090327 | negative regulation of locomotion involved in locomotory behavior | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0044020 | histone methyltransferase activity (H4-R3 specific) | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0060159 | regulation of dopamine receptor signaling pathway | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0060161 | positive regulation of dopamine receptor signaling pathway | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0006382 | adenosine to inosine editing | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0070784 | regulation of growth of unicellular organism as a thread of attached cells | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0090365 | regulation of mRNA modification | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0034970 | histone H3-R2 methylation | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0021670 | lateral ventricle development | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:1904888 | cranial skeletal system development | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0042400 | ectoine catabolic process | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:1903748 | negative regulation of establishment of protein localization to mitochondrion | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0001700 | embryonic development via the syncytial blastoderm | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0042809 | nuclear vitamin D receptor binding | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0072429 | response to intra-S DNA damage checkpoint signaling | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:1903463 | regulation of mitotic cell cycle DNA replication | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:1904512 | regulation of initiation of premeiotic DNA replication | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:1904514 | positive regulation of initiation of premeiotic DNA replication | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:1905261 | regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0005093 | Rab GDP-dissociation inhibitor activity | 0.82% (1/122) | 6.32 | 0.012427 | 0.040443 |
GO:0006163 | purine nucleotide metabolic process | 4.1% (5/122) | 1.86 | 0.012523 | 0.040608 |
GO:0040008 | regulation of growth | 9.84% (12/122) | 1.07 | 0.012182 | 0.041136 |
GO:0010948 | negative regulation of cell cycle process | 3.28% (4/122) | 2.16 | 0.012716 | 0.041185 |
GO:0007611 | learning or memory | 2.46% (3/122) | 2.63 | 0.012802 | 0.041364 |
GO:0005684 | U2-type spliceosomal complex | 2.46% (3/122) | 2.63 | 0.012802 | 0.041364 |
GO:0002705 | positive regulation of leukocyte mediated immunity | 1.64% (2/122) | 3.54 | 0.01288 | 0.041371 |
GO:0050766 | positive regulation of phagocytosis | 1.64% (2/122) | 3.54 | 0.01288 | 0.041371 |
GO:1905369 | endopeptidase complex | 1.64% (2/122) | 3.54 | 0.01288 | 0.041371 |
GO:0045859 | regulation of protein kinase activity | 3.28% (4/122) | 2.15 | 0.012865 | 0.041468 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | 4.1% (5/122) | 1.85 | 0.012863 | 0.041513 |
GO:0051015 | actin filament binding | 2.46% (3/122) | 2.62 | 0.013024 | 0.041632 |
GO:0009640 | photomorphogenesis | 2.46% (3/122) | 2.62 | 0.013024 | 0.041632 |
GO:0031331 | positive regulation of cellular catabolic process | 4.1% (5/122) | 1.85 | 0.012978 | 0.041635 |
GO:0034605 | cellular response to heat | 3.28% (4/122) | 2.15 | 0.013014 | 0.041702 |
GO:0019904 | protein domain specific binding | 4.92% (6/122) | 1.63 | 0.013393 | 0.042763 |
GO:0008135 | translation factor activity, RNA binding | 2.46% (3/122) | 2.6 | 0.013474 | 0.04297 |
GO:0072594 | establishment of protein localization to organelle | 4.1% (5/122) | 1.83 | 0.013682 | 0.043583 |
GO:0050863 | regulation of T cell activation | 1.64% (2/122) | 3.49 | 0.013787 | 0.043866 |
GO:0070918 | small regulatory ncRNA processing | 2.46% (3/122) | 2.59 | 0.013933 | 0.044277 |
GO:0071702 | organic substance transport | 11.48% (14/122) | 0.94 | 0.014177 | 0.045 |
GO:0045292 | mRNA cis splicing, via spliceosome | 1.64% (2/122) | 3.47 | 0.014251 | 0.045075 |
GO:0043204 | perikaryon | 1.64% (2/122) | 3.47 | 0.014251 | 0.045075 |
GO:0051787 | misfolded protein binding | 1.64% (2/122) | 3.47 | 0.014251 | 0.045075 |
GO:0047484 | regulation of response to osmotic stress | 4.1% (5/122) | 1.82 | 0.014288 | 0.04514 |
GO:0008047 | enzyme activator activity | 3.28% (4/122) | 2.1 | 0.014413 | 0.045429 |
GO:0009259 | ribonucleotide metabolic process | 4.1% (5/122) | 1.81 | 0.014412 | 0.045476 |
GO:0098926 | postsynaptic signal transduction | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0099527 | postsynapse to nucleus signaling pathway | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0043273 | CTPase activity | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0020027 | hemoglobin metabolic process | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0097400 | interleukin-17-mediated signaling pathway | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:1903832 | regulation of cellular response to amino acid starvation | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:1903833 | positive regulation of cellular response to amino acid starvation | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0051292 | nuclear pore complex assembly | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0004526 | ribonuclease P activity | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0062028 | regulation of stress granule assembly | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0005540 | hyaluronic acid binding | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0035262 | gonad morphogenesis | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:1990634 | protein phosphatase 5 binding | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0001776 | leukocyte homeostasis | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0006370 | 7-methylguanosine mRNA capping | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0004794 | L-threonine ammonia-lyase activity | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0043508 | negative regulation of JUN kinase activity | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0031389 | Rad17 RFC-like complex | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:1902296 | DNA strand elongation involved in cell cycle DNA replication | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:1902319 | DNA strand elongation involved in nuclear cell cycle DNA replication | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:1902983 | DNA strand elongation involved in mitotic DNA replication | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0090666 | scaRNA localization to Cajal body | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:1904874 | positive regulation of telomerase RNA localization to Cajal body | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0071232 | cellular response to histidine | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0035974 | meiotic spindle pole body | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:1902570 | protein localization to nucleolus | 0.82% (1/122) | 6.0 | 0.015509 | 0.047229 |
GO:0048573 | photoperiodism, flowering | 3.28% (4/122) | 2.09 | 0.015064 | 0.047426 |
GO:0050890 | cognition | 2.46% (3/122) | 2.54 | 0.015119 | 0.047543 |
GO:0030665 | clathrin-coated vesicle membrane | 1.64% (2/122) | 3.39 | 0.015681 | 0.047699 |
GO:1902105 | regulation of leukocyte differentiation | 1.64% (2/122) | 3.42 | 0.015198 | 0.047735 |
GO:0019693 | ribose phosphate metabolic process | 4.1% (5/122) | 1.78 | 0.015816 | 0.048053 |
GO:0032886 | regulation of microtubule-based process | 2.46% (3/122) | 2.52 | 0.015858 | 0.048126 |
GO:0035556 | intracellular signal transduction | 7.38% (9/122) | 1.22 | 0.016045 | 0.048639 |
GO:0005048 | signal sequence binding | 1.64% (2/122) | 3.37 | 0.016171 | 0.048859 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 1.64% (2/122) | 3.37 | 0.016171 | 0.048859 |
GO:0005776 | autophagosome | 1.64% (2/122) | 3.37 | 0.016171 | 0.048859 |